Eric McFee Parker is a notable inventor based in Scotch Plains, NJ (US). He has made significant contributions to the field of therapeutic treatments, holding a total of 2 patents. His work focuses on innovative methods for addressing complex medical conditions.

Latest Patents

Parker's latest patents include "Methods and therapeutic combinations for the treatment of demyelination." This invention provides methods for treating demyelination and associated conditions by administering at least one sterol absorption inhibitor. The therapeutic combinations can be useful for preventing or treating demyelination and associated conditions, such as multiple sclerosis. Another significant patent is for "Chimeric mammalian NPY Y.sub.5 receptors." This invention offers mammalian chimeric NPY Y.sub.5 receptors, nucleic acids, and vectors encoding the receptors. It also includes methods for making the receptors and using them in screening systems to identify compounds for the treatment of various diseases.

Career Highlights

Eric McFee Parker is associated with Schering Corporation, where he has been able to apply his innovative ideas in a collaborative environment. His work has contributed to advancements in therapeutic methods that can potentially improve patient outcomes.

Collaborations

Parker has worked alongside notable colleagues such as Jay S Fine and Mark Stephen Rudinski. Their collaborative efforts have further enhanced the development of innovative solutions in the medical field.

Conclusion

Eric McFee Parker is a distinguished inventor whose work in therapeutic treatments has the potential to make a significant impact on healthcare. His patents reflect a commitment to advancing medical science and improving the lives of individuals affected by demyelination and other conditions.